You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The project aims to develop high-content, multiplex assays capable of simultaneously detecting 35 National Institute of Allergy and Infectious Diseases category A, B, and C viral agents, plus quantifying cytokine and chemokine responses in patients.
National Taiwan University, NanoString Technologies, Agilent Technologies, Asuragen, Children's Hospital & Research Center, Corning, Advanced Liquid Logic, Health Discovery
The firm is positioning the nCounter Human Karyotype Panel as a faster, less expensive alternative to microarray-based approaches.
NanoString hires Chris Grimley as VP of marketing and Katherine Webster as VP of worldwide sales.
Chris Grimley, Katherine Webster
Christine Meda, J. Wayne Cowens
NanoString names Wayne Cowens as CMO.
A recent licensing agreement for a panel of genes for breast cancer detection "marks really the debut of NanoString as a serious diagnostics developer," President and CEO Brad Gray said.
Agilent's SureSelect XT Mouse All Exon kit; NanoString's nCounter Mouse miRNA Expression kit; Ipsogen's BCR-ABL Mbcr IS-MMR kits; ATCC's Universal Mycoplasma Detection kit.
The Wall Street Journal reports that Russia's announcement of a coronavirus vaccine approval was met with concern as safety testing has not yet been completed.
New Scientist writes there aren't much data available on the accuracy of the two rapid COVID-19 tests the UK plans to roll out.
In PNAS this week: downstream effect of oncoprotein fusion, epigenetic changes influence tRNAs in colon cancer, and more.
Nature News reports that recent proposed changes to the US National Science Foundation have raised concerns about a shift away from the agency's focus on basic research.